loadpatents
name:-0.034940004348755
name:-0.012156963348389
name:-0.0015621185302734
Lieberburg; Ivan Patent Filings

Lieberburg; Ivan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lieberburg; Ivan.The latest application filed is for "methods of treating inflammatory and autoimmune diseases with natalizumab".

Company Profile
1.16.33
  • Lieberburg; Ivan - Berkeley CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods of treating inflammatory and autoimmune diseases with natalizumab
Grant 11,292,845 - Lieberburg April 5, 2
2022-04-05
Methods Of Treating Inflammatory And Autoimmune Diseases With Natalizumab
App 20190315871 - Lieberburg; Ivan
2019-10-17
Methods of treating inflammatory and autoimmune diseases with natalizumab
Grant 10,233,245 - Lieberburg
2019-03-19
Methods Of Treating Inflammatory And Autoimmune Diseases With Natalizumab
App 20170247457 - Lieberburg; Ivan
2017-08-31
Immunotherapy regimes dependent on ApoE status
Grant 9,644,025 - Black , et al. May 9, 2
2017-05-09
Methods Of Treating Inflammatory And Autoimmune Diseases With Natalizumab
App 20170022276 - Lieberburg; Ivan
2017-01-26
Methods of treating inflammatory and autoimmune diseases with natalizumab
Grant 9,493,567 - Lieberburg November 15, 2
2016-11-15
Use of tau to monitor immunotherapy
Grant 9,272,030 - Black , et al. March 1, 2
2016-03-01
Use Of Tau To Monitor Immunotherapy
App 20150118223 - Black; Ronald ;   et al.
2015-04-30
Steroid Sparing Agents And Methods Of Using Same
App 20150056205 - LIEBERBURG; Ivan
2015-02-26
Treatment of amyloidogenic diseases
Grant 8,784,810 - Lieberburg , et al. July 22, 2
2014-07-22
Methods Of Treating Inflammatory And Autoimmune Diseases With Alpha-4 Inhibitory Compounds
App 20140051655 - Lieberburg; Ivan
2014-02-20
Treatment of amyloidogenic diseases
Grant 8,613,920 - Lieberburg , et al. December 24, 2
2013-12-24
Use Of Tau To Monitor Immunotherapy
App 20130209453 - Black; Ronald ;   et al.
2013-08-15
Methods of treating inflammatory and autoimmune diseases with alpha-4 inhibitory compounds
Grant 8,410,115 - Lieberburg April 2, 2
2013-04-02
Methods and compositions for treating liquid tumors
Grant 8,269,009 - Messersmith , et al. September 18, 2
2012-09-18
Immunotherapy Regimes Dependent On Apoe Status
App 20120070379 - Black; Ronald ;   et al.
2012-03-22
Treatment Of Amyloidogenic Diseases
App 20110229413 - Lieberburg; Ivan ;   et al.
2011-09-22
Immunotherapy Regimes Dependent On Apoe Status
App 20100266505 - Black; Ronald ;   et al.
2010-10-21
Treatment Of Amyloidogenic Diseases
App 20100221187 - Lieberburg; Ivan ;   et al.
2010-09-02
Methods of Treating Inflammatory and Autoimmune Diseases with Natalizumab
App 20100196318 - Lieberburg; Ivan
2010-08-05
Methods and compositions for treating liquid tumors
App 20090312353 - Messersmith; Elizabeth ;   et al.
2009-12-17
Methods and compositions for treating rheumatoid arthritis
Grant 7,605,166 - Yednock , et al. October 20, 2
2009-10-20
Immunotherapy Regimes Dependent On APOE Status
App 20090155256 - Black; Ronald ;   et al.
2009-06-18
Combination therapy for treatment of demyelinating conditions
App 20080089861 - Went; Gregory T. ;   et al.
2008-04-17
Methods of treating inflammatory and autoimmune diseases with alpha-4 inhibitory compounds
App 20080044382 - Lieberburg; Ivan
2008-02-21
Methods of treating inflammatory and autoimmune diseases with natalizumab
App 20070207141 - Lieberburg; Ivan
2007-09-06
Steroid sparing agents and methods of using same
App 20060004019 - Lieberburg; Ivan
2006-01-05
Steroid sparing agents and methods of using same
App 20050260193 - Lieberburg, Ivan
2005-11-24
Methods of using zonisamide as an adjunctive therapy for partial seizures
App 20050154037 - Lieberburg, Ivan
2005-07-14
Methods of using zonisamide as an adjunctive therapy for partial seizures
App 20050154035 - Lieberburg, Ivan
2005-07-14
Methods of using zonisamide as an adjunctive therapy for partial seizures
App 20050154032 - Lieberburg, Ivan
2005-07-14
Methods of using zonisamide as an adjunctive therapy for partial seizures
App 20050154036 - Lieberburg, Ivan
2005-07-14
Methods of using zonisamide as an adjunctive therapy for partial seizures
App 20050154033 - Lieberburg, Ivan
2005-07-14
Methods of using zonisamide as an adjunctive therapy for partial seizures
App 20050154034 - Lieberburg, Ivan
2005-07-14
Methods and compositions for treating rheumatoid arthritis
App 20050074451 - Yednock, Theodore A. ;   et al.
2005-04-07
Methods and compositions for treating rheumatoid arthritis
App 20050065192 - Yednock, Theodore A. ;   et al.
2005-03-24
Methods of using zonisamide as an adjunctive therapy for partial seizures
App 20050059718 - Miyachi, Hayato ;   et al.
2005-03-17
Methods of using zonisamide as an adjunctive therapy for partial seizures
App 20050043705 - Lieberburg, Ivan
2005-02-24
Methods of using zonisamide as an adjunctive therapy for partial seizures
App 20050043704 - Lieberburg, Ivan
2005-02-24
Methods of improving the safety of zonisamide therapy
App 20050043773 - Lieberburg, Ivan
2005-02-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed